In my opinion, I believe that the Food and Drug Administration (FDA) should have mentioned the EpiPen characteristics that made the product unsafe. For example, instead of broadly saying that the company didn’t follow the guidelines and had product failures, they could have explained in more detail the exact thing that wasn’t right. I would have also liked to see some visual representations of the EpiPen to see the differences of how Mylan was selling the product in comparison to how it should be sold in order to understand the major differences. Although I have mixed emotions on this situation and about whether this unsafe product is more of the manufacturers fault or the company that sells this product for not doing enough research to make
